QuidelOrtho EBITDA Margin 2012-2025 | QDEL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for QuidelOrtho (QDEL) over the last 10 years. The current EBITDA margin for QuidelOrtho as of September 30, 2025 is .
| QuidelOrtho EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $2.72B | $0.27B | 9.80% |
| 2025-06-30 | $2.74B | $0.29B | 10.43% |
| 2025-03-31 | $2.77B | $0.36B | 12.84% |
| 2024-12-31 | $2.78B | $0.32B | 11.35% |
| 2024-09-30 | $2.82B | $0.38B | 13.63% |
| 2024-06-30 | $2.84B | $0.40B | 13.93% |
| 2024-03-31 | $2.86B | $0.48B | 16.91% |
| 2023-12-31 | $3.00B | $0.60B | 19.91% |
| 2023-09-30 | $3.12B | $0.64B | 20.63% |
| 2023-06-30 | $3.16B | $0.67B | 21.07% |
| 2023-03-31 | $3.11B | $0.71B | 22.68% |
| 2022-12-31 | $3.27B | $1.13B | 34.52% |
| 2022-09-30 | $3.04B | $1.32B | 43.35% |
| 2022-06-30 | $2.76B | $1.45B | 52.50% |
| 2022-03-31 | $2.33B | $1.36B | 58.34% |
| 2021-12-31 | $1.70B | $0.96B | 56.44% |
| 2021-09-30 | $1.87B | $1.19B | 63.66% |
| 2021-06-30 | $1.84B | $1.22B | 66.30% |
| 2021-03-31 | $1.86B | $1.28B | 68.80% |
| 2020-12-31 | $1.66B | $1.11B | 66.73% |
| 2020-09-30 | $1.01B | $0.53B | 53.03% |
| 2020-06-30 | $0.66B | $0.25B | 37.56% |
| 2020-03-31 | $0.56B | $0.17B | 30.30% |
| 2019-12-31 | $0.53B | $0.15B | 28.09% |
| 2019-09-30 | $0.52B | $0.14B | 27.96% |
| 2019-06-30 | $0.51B | $0.16B | 32.21% |
| 2019-03-31 | $0.50B | $0.13B | 26.75% |
| 2018-12-31 | $0.52B | $0.16B | 29.89% |
| 2018-09-30 | $0.50B | $0.14B | 26.79% |
| 2018-06-30 | $0.44B | $0.09B | 19.63% |
| 2018-03-31 | $0.37B | $0.09B | 24.13% |
| 2017-12-31 | $0.28B | $0.05B | 17.27% |
| 2017-09-30 | $0.22B | $0.04B | 18.52% |
| 2017-06-30 | $0.21B | $0.04B | 20.56% |
| 2017-03-31 | $0.22B | $0.05B | 21.86% |
| 2016-12-31 | $0.19B | $0.03B | 13.09% |
| 2016-09-30 | $0.19B | $0.02B | 11.58% |
| 2016-06-30 | $0.19B | $0.02B | 11.17% |
| 2016-03-31 | $0.18B | $0.02B | 10.33% |
| 2015-12-31 | $0.20B | $0.03B | 15.82% |
| 2015-09-30 | $0.21B | $0.04B | 20.10% |
| 2015-06-30 | $0.20B | $0.03B | 15.27% |
| 2015-03-31 | $0.20B | $0.03B | 15.08% |
| 2014-12-31 | $0.18B | $0.02B | 10.33% |
| 2014-09-30 | $0.17B | $0.01B | 2.92% |
| 2014-06-30 | $0.16B | $0.01B | 5.49% |
| 2014-03-31 | $0.16B | $0.01B | 6.75% |
| 2013-12-31 | $0.18B | $0.03B | 16.85% |
| 2013-09-30 | $0.18B | $0.05B | 25.00% |
| 2013-06-30 | $0.18B | $0.05B | 26.82% |
| 2013-03-31 | $0.18B | $0.05B | 28.33% |
| 2012-12-31 | $0.16B | $0.03B | 21.15% |
| 2012-09-30 | $0.14B | $0.02B | 13.57% |
| 2012-06-30 | $0.14B | $0.02B | 13.57% |
| 2012-03-31 | $0.14B | $0.02B | 11.68% |
| 2011-12-31 | $0.16B | $0.03B | 19.50% |
| 2011-09-30 | $0.15B | $0.03B | 16.99% |
| 2011-06-30 | $0.15B | $0.02B | 14.86% |
| 2011-03-31 | $0.15B | $0.02B | 13.79% |
| 2010-12-31 | $0.11B | $0.00B | -2.65% |
| 2010-09-30 | $0.15B | $0.03B | 18.92% |
| 2010-06-30 | $0.18B | $0.05B | 30.68% |
| 2010-03-31 | $0.18B | $0.06B | 34.09% |
| 2009-12-31 | $0.17B | $0.06B | 35.76% |
| 2009-09-30 | $0.13B | $0.04B | 27.48% |
| 2009-06-30 | $0.11B | $0.02B | 17.76% |
| 2009-03-31 | $0.10B | $0.02B | 17.31% |
| 2008-12-31 | $0.13B | $0.04B | 28.91% |
| 2008-09-30 | $0.13B | $0.04B | 30.08% |
| 2008-06-30 | $0.13B | $0.04B | 28.68% |
| 2008-03-31 | $0.13B | $0.04B | 27.78% |
| 2007-12-31 | $0.12B | $0.03B | 24.37% |
| 2007-09-30 | $0.12B | $0.03B | 24.17% |
| 2007-06-30 | $0.12B | $0.03B | 23.28% |
| 2007-03-31 | $0.11B | $0.03B | 23.01% |
| 2006-12-31 | $0.11B | $0.02B | 21.70% |
| 2006-09-30 | $0.10B | $0.02B | 20.59% |
| 2006-06-30 | $0.10B | $0.02B | 20.41% |
| 2006-03-31 | $0.10B | $0.02B | 21.65% |
| 2005-12-31 | $0.09B | $0.02B | 19.35% |
| 2005-09-30 | $0.09B | $0.01B | 15.56% |
| 2005-06-30 | $0.08B | $0.01B | 7.14% |
| 2005-03-31 | $0.08B | $0.00B | 4.82% |
| 2004-12-31 | $0.08B | $0.00B | 1.27% |
| 2004-09-30 | $0.08B | $0.01B | 6.41% |
| 2004-06-30 | $0.08B | $0.01B | 10.84% |
| 2004-03-31 | $0.09B | $0.01B | 13.64% |
| 2003-12-31 | $0.09B | $0.01B | 15.05% |
| 2003-09-30 | $0.08B | $0.01B | 8.54% |
| 2003-06-30 | $0.08B | $0.01B | 7.69% |
| 2003-03-31 | $0.08B | $0.01B | 9.09% |
| 2002-12-31 | $0.07B | $0.01B | 9.46% |
| 2002-09-30 | $0.08B | $0.00B | 3.95% |
| 2002-06-30 | $0.08B | $0.01B | 7.69% |
| 2002-03-31 | $0.08B | $0.00B | 5.26% |
| 2001-12-31 | $0.08B | $0.00B | 2.67% |
| 2001-09-30 | $0.07B | $0.00B | 1.39% |
| 2001-06-30 | $0.07B | $0.00B | -5.97% |
| 2001-03-31 | $0.07B | $0.00B | -4.41% |
| 2000-12-31 | $0.07B | $0.00B | -2.86% |
| 2000-09-30 | $0.07B | $0.05B | 73.91% |
| 2000-06-30 | $0.07B | $0.05B | 78.26% |
| 2000-03-31 | $0.06B | $0.05B | 80.95% |
| 1999-12-31 | $0.06B | $0.05B | 96.36% |
| 1999-09-30 | $0.05B | $0.00B | 3.85% |
| 1999-06-30 | $0.05B | $0.00B | 4.00% |
| 1999-03-31 | $0.05B | $0.00B | 4.08% |
| 1998-12-31 | $0.05B | $0.02B | 32.00% |
| 1998-09-30 | $0.05B | $0.03B | 56.25% |
| 1998-06-30 | $0.05B | $0.03B | 68.00% |
| 1998-03-31 | $0.05B | $0.04B | 85.71% |
| 1997-12-31 | $0.05B | $0.03B | 65.96% |
| 1997-09-30 | $0.05B | $0.02B | 45.65% |
| 1997-06-30 | $0.04B | $0.02B | 36.36% |
| 1997-03-31 | $0.05B | $0.01B | 22.22% |
| 1996-12-31 | $0.04B | $0.01B | 12.20% |
| 1996-09-30 | $0.04B | $0.00B | 7.89% |
| 1996-06-30 | $0.04B | $0.00B | 5.56% |
| 1996-03-31 | $0.04B | $0.00B | 8.57% |
| 1995-12-31 | $0.04B | $0.00B | 5.56% |
| 1995-09-30 | $0.04B | $0.00B | 5.56% |
| 1995-06-30 | $0.04B | $0.00B | 2.86% |
| 1995-03-31 | $0.03B | $0.00B | -3.23% |
| 1994-12-31 | $0.03B | $0.00B | -6.90% |
| 1994-09-30 | $0.03B | $0.00B | -10.71% |
| 1994-06-30 | $0.03B | $0.00B | -7.14% |
| 1994-03-31 | $0.03B | 0 | 0.00% |
| 1993-12-31 | $0.03B | $0.00B | 6.45% |
| 1993-09-30 | $0.03B | $0.00B | 6.45% |
| 1993-06-30 | $0.03B | $0.00B | 6.67% |
| 1993-03-31 | $0.03B | $0.00B | 6.90% |
| 1992-12-31 | $0.03B | $0.00B | 7.41% |
| 1992-09-30 | $0.03B | $0.00B | 7.69% |
| 1992-06-30 | $0.03B | $0.00B | 7.69% |
| 1992-03-31 | $0.03B | $0.00B | 7.41% |
| 1991-09-30 | $0.02B | $0.00B | 13.33% |
| 1991-06-30 | $0.01B | $0.00B | 18.18% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.984B | $2.783B |
| QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.241B | 21.80 |
| EssilorLuxottica (ESLOY) | France | $138.190B | 0.00 |
| Stryker (SYK) | United States | $138.078B | 26.49 |
| Medtronic (MDT) | Ireland | $130.022B | 18.01 |
| Boston Scientific (BSX) | United States | $110.071B | 24.34 |
| Medline (MDLN) | United States | $59.498B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.159B | 0.00 |
| ResMed (RMD) | United States | $38.392B | 25.64 |
| Agilent Technologies (A) | United States | $36.486B | 23.12 |
| GE HealthCare Technologies (GEHC) | United States | $36.105B | 17.30 |
| Koninklijke Philips (PHG) | Netherlands | $31.690B | 18.81 |
| Terumo (TRUMY) | Japan | $20.046B | 22.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.114B | 11.15 |
| Insulet (PODD) | United States | $17.756B | 55.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.032B | 0.00 |
| Baxter (BAX) | United States | $11.278B | 9.10 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.091B | 29.09 |
| Demant (WILYY) | Denmark | $6.264B | 0.00 |
| Envista Holdings (NVST) | United States | $4.961B | 25.14 |
| Lantheus Holdings (LNTH) | United States | $4.454B | 13.57 |
| BillionToOne (BLLN) | United States | $4.208B | 0.00 |
| ICU Medical (ICUI) | United States | $3.782B | 24.02 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.128B | 14.76 |
| Haemonetics (HAE) | United States | $2.763B | 12.09 |
| Neogen (NEOG) | United States | $2.334B | 51.10 |
| Phibro Animal Health (PAHC) | United States | $2.097B | 18.48 |
| LeMaitre Vascular (LMAT) | United States | $1.996B | 40.17 |
| Perrigo (PRGO) | Ireland | $1.980B | 4.96 |
| AtriCure (ATRC) | United States | $1.882B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.615B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.593B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.441B | 20.86 |
| Green Thumb Industries (GTBIF) | United States | $1.423B | 62.36 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.325B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.126B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.091B | 323.57 |
| InMode (INMD) | Israel | $0.924B | 10.15 |
| Tilray Brands (TLRY) | Canada | $0.912B | 0.00 |
| Valneva SE (VALN) | France | $0.846B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.798B | 0.00 |
| Omeros (OMER) | United States | $0.792B | 0.00 |
| CeriBell (CBLL) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 14.15 |
| Brainsway (BWAY) | Israel | $0.457B | 77.83 |
| Verano Holdings (VRNO) | United States | $0.447B | 0.00 |
| Cerus (CERS) | United States | $0.428B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.368B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.12 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.288B | 0.00 |
| Quanterix (QTRX) | United States | $0.286B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.227B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.221B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 18.54 |
| Aurora Cannabis (ACB) | Canada | $0.202B | 59.33 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.200B | 0.00 |
| Organigram Global (OGI) | Canada | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.184B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.174B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.166B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.86 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Biote (BTMD) | United States | $0.101B | 4.42 |
| Exagen (XGN) | United States | $0.079B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.50 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.92 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.56 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |